Latest Retail News

Ryman Healthcare has opened a NZ$100 million fixed rate bond offer maturing in 2032, featuring an exchange mechanism for existing bondholders and a minimum interest rate of 5.60%. The offer targets institutional and retail investors and aims to refinance debt and diversify funding.

EBR Systems has secured A$106.4 million through a fully underwritten institutional placement and entitlement offer, positioning the company for further commercial expansion of its wireless cardiac pacing technology.

Meridian Energy has secured a draft decision allowing greater access to Lake Pūkaki’s hydro storage contingent reserves, with plans to moderate usage amid supply risk concerns.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Arafura Rare Earths has officially opened its share purchase plan following ASIC lodgement, while also dispatching notices for a July extraordinary general meeting in Perth.

OMG Group's net sales hit approximately $6.2 million on a moving annual total basis, marking a 57% increase year-on-year, driven by ecommerce growth and key international distribution deals.

The ACCC has approved Ampol’s acquisition of EG Australia, mandating the sale of 41 overlapping fuel retail sites to Metro Petroleum to maintain competition across 39 local markets.

Ampol's acquisition of EG Australia has gained ACCC approval, conditional on divesting 41 overlapping fuel sites to Metro Petroleum to preserve competition in 39 local markets.

Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.

Superloop Limited upgrades FY26 underlying EBITDA guidance to $118-$122 million, driven by strong trading and the Lightning Broadband acquisition, while launching a bold three-year Supercharge29 strategy targeting sustained growth and shareholder returns.

Pacific Edge has secured NZ$36.1 million through a combination of a NZ$25.4 million placement and a significantly oversubscribed retail offer, reinforcing its strategic position to expand the Cxbladder cancer diagnostic platform.

Scales Corporation has declared a final FY2025 dividend of 12.5 cents per share, lifting total dividends for the year to 25 cents, representing 59% of underlying net profit. The company also introduced a Dividend Reinvestment Plan offering shares at a 2% discount.